Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study

Statins and cancer: Current and future prospects

(2012) Maja Osmak   CANCER LETTERS

AMPK  Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer

(2012) Y. H. Kim et al.   CANCER RESEARCH

Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data

(2012) Seo-Young Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo

(2012) K. Kato et al.   MOLECULAR CANCER THERAPEUTICS

High-Quality, Low-Cost Gastrectomy Care at High-Volume Hospitals

(2011) Jung A. Lee   ARCHIVES OF SURGERY

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

(2011) Meei-Shyuan Lee et al.   BMC CANCER

Cellular and molecular mechanisms of metformin: an overview

(2011) Benoit Viollet et al.   CLINICAL SCIENCE

Gastric Cancer: Clinical Aspects, Epidemiology and Molecular Background

(2011) Jan Bornschein et al.   HELICOBACTER

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus

(2011) Chia-Hsuin Chang et al.   HEPATOLOGY

Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase

(2010) Kristy A. Brown et al.   BREAST CANCER RESEARCH AND TREATMENT

Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation

(2010) K Masur et al.   BRITISH JOURNAL OF CANCER

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) M. Monami et al.   DIABETES CARE

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

(2010) M. Bodmer et al.   DIABETES CARE

Metformin: Taking away the candy for cancer?

(2010) Mathilde Jalving et al.   EUROPEAN JOURNAL OF CANCER

Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan

(2010) C.-H. Tseng   GUT

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

(2010) Dorothee M. Baur et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diabetes Mellitus and Increased Risk of Cancer: Focus on Metformin and the Insulin Analogs

(2010) M. Shawn McFarland et al.   PHARMACOTHERAPY

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Helicobacter pylori Infection Significantly Increases Insulin Resistance in the Asymptomatic Japanese Population

(2009) Toshiaki Gunji et al.   HELICOBACTER

Aspirin, salicylates, and cancer

(2009) Peter C Elwood et al.   LANCET

Sulphonylureas and cancer: a case–control study

(2008) Matteo Monami et al.   ACTA DIABETOLOGICA

The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase

(2008) M. Zakikhani et al.   Cancer Prevention Research

Hyperglycemia Increases Risk of Gastric Cancer Posed by Helicobacter pylori Infection: A Population-Based Cohort Study

(2008) Fumie Ikeda et al.   GASTROENTEROLOGY

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE